PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Advanced Breast Cancer|Hormone Receptor Positive Tumor|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Interventions: DRUG: Palbociclib|DRUG: Endocrine therapy
Sponsor: MedSIR
Collaborators: Pfizer